Menstrual changes following COVID-19 vaccination
There is an increase in the incidence of menstrual changes among young women after vaccination against coronavirus, according to initial findings by the NIPH.
News
Published Updated
News
Showing 18 hits
-
-
Offer of coronavirus immunisation for children and adolescents expanded
Following a recommendation from the Norwegian Institute of Public Health, the Government has decided to offer coronavirus vaccines to children aged 5–11 and a second dose to 12–15-year-olds.
News
Published
-
Say yes when you are offered a booster dose
Due to the rapid spread of the omicron variant, everyone who is recommended to have a booster dose should accept the coronavirus vaccine they are offered.
News
Published
-
More people will be offered a booster dose
Everyone aged 45 years and older will be offered a booster dose.
News
Published Updated
-
NIPH is following new coronavirus variant
The NIPH is working to obtain more information and assess the new virus variant discovered in South Africa. It is still too early to say which consequences the new variant may have for the infection situation in Norway.
News
Published
-
Easier access to third dose for people with suppressed immune systems
Together with the medical communities and specialist healthcare service, the Norwegian Institute of Public Health (NIPH) has compiled an overview of the diseases that people who are recommended to take the third dose have, and which medication they use.
News
Published
-
Shorter hospital stays for people who are fully vaccinated
Fully vaccinated people have shorter hospital stays and a lower risk of needing intensive care treatment, according to a new study from the Norwegian Institute of Public Health.
Research findings
Published
-
No indication of an increased risk of miscarriage after vaccination against COVID-19
Pregnant women who have been vaccinated against COVID-19 have no apparent increased risk of miscarriage, according to a new study from the Centre for Fertility and Health at the Norwegian Institute of Public Health (NIPH).
Research findings
Published
-
Myocarditis in boys and young men can occur more often after the Spikevax vaccine from Moderna
Myocarditis (inflammation of the heart muscle) is a rare side effect of mRNA vaccines. The side effect is observed especially in boys and young men and mainly after the second dose. Updated knowledge indicates that this occurs more often with the use of Moderna's vaccine Spikevax than BioNTech / Pfizer's vaccine Comirnaty. This seems to apply regardless of which mRNA vaccine was given as the first dose.
News
Published
-
Persons vaccinated with Janssen will be offered an additional dose of mRNA vaccine
The Ministry of Health and Care Services has decided to follow the National Institute of Public Health's recommendation to offer an extra dose of mRNA vaccine to those who have received one dose of the Janssen vaccine.
News
Published
-
Booster dose for the elderly and nursing home residents
The Government has, in accordance with the advice of the National Institute of Public Health (NIPH), decided to offer an additional dose (booster dose) to the older age groups. It is recommended to start with vaccination for the age group 85 years and older as well as nursing home residents. The additional dose can be given no earlier than 6 months after receiving their second vaccine dose. The offer to the age group 85 years and above will be followed by booster vaccination in stages of the age group 75-84 and then the age group 65-74.
News
Published
-
Mild COVID-19 disease and few long-term effects among children
COVID-19 is generally not dangerous for children and adolescents. Infected children and adolescents most often have very mild symptoms of COVID-19, and 20-30 % have no symptoms at all.
News
Published
-
12-15-year-olds will be offered coronavirus vaccination
The Government has decided to follow the Norwegian Institute of Public Health's recommendation to offer coronavirus vaccination to adolescents aged 12-15 years.
News
Published
-
16-17-year-olds to be offered coronavirus vaccination
The Government has decided that 16 and 17-year-olds in Norway will be offered coronavirus vaccination, based on advice from the Norwegian Institute of Public Health.
News
Published
-
Updated vaccine recommendations for pregnant women
Pregnant women have a slightly increased risk of a severe COVID-19 disease course, and there is more knowledge about vaccinating pregnant women. The NIPH recommends that all pregnant women are vaccinated against COVID-19.
News
Published
-
Norway receives over 1 million more coronavirus vaccine doses
The government has entered into an agreement to secure 1,000,800 extra coronavirus vaccine doses for Norway. The increase means that the entire population over the age of 18 will be offered two doses within week 36.
News
Published
-
Vaccines from BioNTech / Pfizer and Moderna can be combined
Combining vaccines provides similar protection and carries no greater risk of serious side effects than having both vaccines from the same manufacturer.
News
Published
-
What can vaccinated people do now?
We have increasingly reliable knowledge that coronavirus vaccines give good protection against becoming ill and from infecting others. We can use that knowledge to ease measures where possible.
News
Published